---
title: "HCRX.US (HCRX.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/HCRX.US/news.md"
symbol: "HCRX.US"
name: "HCRX.US"
parent: "https://longbridge.com/zh-HK/quote/HCRX.US.md"
datetime: "2026-03-12T00:18:38.640Z"
locales:
  - [en](https://longbridge.com/en/quote/HCRX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HCRX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HCRX.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/HCRX.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/HCRX.US/news.md)


# HCRX.US (HCRX.US) — 相關新聞

### [UniQure To Sell Royalty Interest In HEMGENIX For Up To $400 Mln](https://longbridge.com/zh-HK/news/87702016.md)
*2023-05-15T14:58:20.000Z*
> Gene therapy company uniQure N.V. (QURE) announced Monday it has entered into a definitive agreement to sell a portion o